235 related articles for article (PubMed ID: 33906722)
21. Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
Nevel KS; Pentsova E; Daras M
Leuk Lymphoma; 2019 Jul; 60(7):1677-1684. PubMed ID: 30648449
[TBL] [Abstract][Full Text] [Related]
22. Classification of cytotoxic T-cell and natural killer cell lymphomas.
Jaffe ES; Krenacs L; Raffeld M
Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
[TBL] [Abstract][Full Text] [Related]
23. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
25. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
26. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
[TBL] [Abstract][Full Text] [Related]
27. Central Nervous System Involvement in Peripheral T Cell Lymphoma.
Chihara D; Oki Y
Curr Hematol Malig Rep; 2018 Feb; 13(1):1-6. PubMed ID: 29374824
[TBL] [Abstract][Full Text] [Related]
28. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Alvarnas JC; Negrin RS; Horning SJ; Hu WW; Long GD; Schriber JR; Stockerl-Goldstein K; Tierney K; Wong R; Blume KG; Chao NJ
Biol Blood Marrow Transplant; 2000; 6(3A):352-8. PubMed ID: 10905773
[TBL] [Abstract][Full Text] [Related]
29. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of primary central nervous system NK/T cell lymphoma: rare and localized aggressive tumour among extranasal NK/T cell tumours.
Miyata-Takata T; Takata K; Kato S; Hu LM; Noujima-Harada M; Chuang SS; Sato Y; Maeda Y; Yoshino T
Histopathology; 2017 Aug; 71(2):287-295. PubMed ID: 28342197
[TBL] [Abstract][Full Text] [Related]
31. Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.
van Besien K; Gisselbrecht C; Pfreundschuh M; Zucca E
Leuk Lymphoma; 2008; 49 Suppl 1():52-8. PubMed ID: 18821433
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children.
Klimentova M; Perminova M; Shelikhova L; Abugova Y; Kobyzeva D; Pershin D; Balashov D; Myakova N; Maschan A; Maschan M
Transplant Cell Ther; 2024 Apr; 30(4):437.e1-437.e11. PubMed ID: 38286354
[TBL] [Abstract][Full Text] [Related]
33. Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
Bhansali RS; Barta SK
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765882
[TBL] [Abstract][Full Text] [Related]
34. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
35. Treatment algorithms for mature T-cell and natural killer-cell neoplasms.
Tse E; Kwong YL
Future Oncol; 2011 Sep; 7(9):1101-12. PubMed ID: 21919697
[TBL] [Abstract][Full Text] [Related]
36. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
[TBL] [Abstract][Full Text] [Related]
37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
38. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.
Bang SM; Kim YK; Park YH; Sohn SK; Lee JJ; Cho EK; Ryoo BY; Chung IJ; Yoon SS; Kim HJ; Lee JH; Yoon HJ; Park S
Leuk Lymphoma; 2005 Nov; 46(11):1599-1604. PubMed ID: 16334486
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.
Paolo C; Lucia F; Anna D
Leuk Lymphoma; 2007 Aug; 48(8):1496-501. PubMed ID: 17701579
[TBL] [Abstract][Full Text] [Related]
40. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]